BCM

Bronte Capital Management Portfolio holdings

AUM $957M
1-Year Est. Return 49.6%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+49.6%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$957M
AUM Growth
-$154M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
46
New
Increased
Reduced
Closed

Top Buys

1
+$11.8M
2
+$3.09M
3
+$2.7M
4
NICE icon
Nice
NICE
+$2.45M
5
TPB icon
Turning Point Brands
TPB
+$2.38M

Top Sells

1
+$34M
2
+$19.7M
3
+$18.4M
4
ABVX
Abivax
ABVX
+$14.9M
5
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$12.7M

Sector Composition

1 Financials 26.88%
2 Healthcare 15.9%
3 Communication Services 14.99%
4 Consumer Staples 11.74%
5 Consumer Discretionary 8.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NICE icon
26
Nice
NICE
$6.98B
$2.3M 0.24%
+20,322
OLED icon
27
Universal Display
OLED
$4.49B
$1.36M 0.14%
+11,653
JRVR icon
28
James River Group Holdings
JRVR
$295M
$786K 0.08%
+123,575
ENVX icon
29
Enovix
ENVX
$1.05B
$84.4K 0.01%
11,550
GUTS icon
30
Fractyl Health
GUTS
$68.2M
$37.2K ﹤0.01%
+16,905
ALEC icon
31
Alector
ALEC
$226M
$30.1K ﹤0.01%
+19,282
CHRS icon
32
Coherus Oncology
CHRS
$237M
$27.4K ﹤0.01%
+19,282
IVVD icon
33
Invivyd
IVVD
$427M
$27.2K ﹤0.01%
+11,012
CRBU icon
34
Caribou Biosciences
CRBU
$185M
$24.8K ﹤0.01%
+15,627
PLRX icon
35
Pliant Therapeutics
PLRX
$78.7M
$22.7K ﹤0.01%
+18,613
FATE icon
36
Fate Therapeutics
FATE
$123M
$22.5K ﹤0.01%
+22,853
MIST icon
37
Milestone Pharmaceuticals
MIST
$145M
$21K ﹤0.01%
+10,414
RANI icon
38
Rani Therapeutics
RANI
$116M
$20.1K ﹤0.01%
+14,868
CCCC icon
39
C4 Therapeutics
CCCC
$262M
$19.2K ﹤0.01%
+10,033
ABVX
40
Abivax
ABVX
$9.8B
– –
-156,747
IJR icon
41
iShares Core S&P Small-Cap ETF
IJR
$90.5B
– –
-95,350
IWO icon
42
iShares Russell 2000 Growth ETF
IWO
$12.3B
– –
0
1
2